Skip to main navigation

Main Menu

About
Our Approach
Pipeline
- Publications
Therapeutic Focus
Careers
- Current Openings
- Faces of Fulcrum
Investor Relations
Contact

News Releases

News Releases

Year

Jan 22, 2021

Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Jan 19, 2021

Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock

Jan 19, 2021

Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock

Jan 19, 2021

Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer

Jan 06, 2021

Fulcrum Therapeutics to Participate in the H.C. Wainwright BioConnect 2021 Conference

Investor Tools

Privacy Policy
EU Privacy Policy
Terms of Use

Twitter
LinkedIn
Instagram

Main Menu

About
Our Approach
Pipeline
- Publications
Therapeutic Focus
Careers
- Current Openings
- Faces of Fulcrum
Investor Relations
Contact